Novavax sees 'several billion-dollar global opportunity' as it plans Ebola vaccine clinical trial by year-end

Novavax Inc.'s singular drug development approach to a possible Ebola vaccine may not only help stop the spread of a future pandemic but also reap major bottom-line rewards...